Human Insulin Market is probable to grow at a CAGR of 12% till 2021

Pune, India, 2017-Jun-27 — /EPR Network/ —Market research future has a cooked research report on global Human Insulin Market. The global Human Insulin Market is growing at an average rate and is expected show the similar trend during forecast period.

The market for Global Human Insulin is expected to reach up to $40 billion by the end of the forecasted period and is expected to grow at a CAGR of 10-12%.

The major factors contributing to the market growth are; increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity.

Human insulin is also known as synthetic insulin which is prepared in laboratory and has same characteristics like natural insulin. Human insulin was developed through the 1960s and 1970s and approved for pharmaceutical use in 1982. Before the invention of human insulin animal insulin, usually a purified form of porcine was used.

However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market. Along with that, delayed onset of action, and various side effects of human insulin are also limiting the growth of this market across the globe.

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/951

Major Key Players

• Biocon Ltd. (India),
• Tonghua Dongbao Pharmaceuticals Co., Ltd. (China),
• Adocia (France.),
• Merck & Co. (U.S.),
• Julphar (UAE),
• Bristol-Myers Squibb Company (U.S.),
• GlaxoSmithKline Plc (U.K.),
• Oramed Pharmaceuticals, Inc. (Israel),
• Novo Nordisk A/S (Denmark),

Key Findings

• Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market
• Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the human insulin market
• Geographically, North America has the largest share in global human insulin market, while Asia-Pacific has emerged as the fastest growing region
• Based on the type, modern human insulin has the largest market share in the human insulin market

Segments:

Global Human Insulin market has been segmented on the basis of types which majorly includes modern human insulin, and traditional human insulin. The modern human insulin is further divided into; long acting human insulin, rapid acting human insulin, and premixed human insulin. Whereas, the traditional human insulin is again categorized into; short acting human insulin, and intermediate acting human insulin.

For More Report Details @ https://www.marketresearchfuture.com/reports/human-insulin-market-951

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312

Email: akash.anand@marketresearchfuture.com